We are Diethyl ethoxymethylenemalonate CAS:87-13-8 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
CAS No: 87-13-8
Product Name: Diethyl ethoxymethylenemalonate
Density: 1.1±0.1 g/cm3
Boiling Point: 280.0±0.0 °C at 760 mmHg
Melting Point: -33°C
Molecular Formula: C10H16O5
Molecular Weight: 216.231
Flash Point: 155.0±0.0 °C
Exact Mass: 216.099777
Vapour Pressure: 0.0±0.5 mmHg at 25°C
Index of Refraction: 1.447
Storage condition: Refrigerator
Water Solubility: insoluble
Appearance: Colorless viscous liquid
Refractive index: 1.4610-1.4630
Intermediates of Omethoate CAS: 1113-02-6.
Intermediates of Kitazine CAS: 13286-32-3.
Intermediates of Dichlorvos CAS: 62-73-7.
Intermediates of Trichlorphon CAS: 52-68-6.
Intermediates of CITRAL CAS: 147060-73-9.
Be used as pesticide intermediate.
Intermediate in the production of Flumequine.
It is an important organic raw material with various active groups in the molecule. It can be polycondensed and cyclized with various substances. It is mainly used for the synthesis of norfloxacin.
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Related News: The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.Cloroformiato de isobutilo CAS:543-27-1 The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.1426129-50-1 The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.L-Valinol The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.